Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosis

Katerina Placek(University of Pennsylvania), Corey T. McMillan(University of Pennsylvania), Philip A. Cook(University of Pennsylvania), Volkan Granit(Biohaven Pharmaceuticals (United States)), John Q. Trojanowski(University of Pennsylvania), Evadnie Rampersaud, Gang Wu(St. Jude Children's Research Hospital), Michael Benatar(University of Miami), Ted M. Burns(University of Virginia), Laura Hennessy(University of Pennsylvania), Vivianna M. Van Deerlin(Hospital of the University of Pennsylvania), Murray Grossman(University of Pennsylvania), Rosa Rademakers(Indiana University – Purdue University Indianapolis), Adam C. Naj(University of Miami), David Walk(University of Minnesota Medical Center), James B. Caress(The University of Texas at San Antonio Health Science Center), Leo McCluskey(University of Pennsylvania), Wenan Chen(St. Jude Children's Research Hospital), Edward B. Lee(University of Pennsylvania), Jeffrey Statland(The University of Texas at San Antonio Health Science Center), Erik P. Pioro(University of British Columbia), Samuel Maiser(University of Minnesota Medical Center), Carlayne E. Jackson(The University of Texas at San Antonio Health Science Center), J. Paul Taylor(St. Jude Children's Research Hospital), Andrea Swenson(The University of Texas at San Antonio Health Science Center), David J. Irwin(Pennsylvania Academic Library Consortium), Colin Quinn(University of Pennsylvania), John Ravits(University of California San Diego), Lauren Elman(University of Pennsylvania), James C. Gee(California University of Pennsylvania), Yuen T. So(Santa Clara Valley Medical Center), Joanne Wuu(University of Miami)
EMBO Molecular Medicine
December 3, 2020
Cited by 27


Related Papers